Balanced news tone
News Sentiment
HSCS sentiment intelligence
Heart Test Laboratories Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-1.8% over one week, +52.2% over four weeks, trend inactive, and below fair value.
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Jul 2026 09:24
- Source
- DirectorsTalk Interviews
HeartSciences (NASDAQ: HSCS) ties CFO severance and 25,000 RSUs to Fortitude merger
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Jul 2026 21:01
- Source
- Stock Titan
Form 4 Heart Test Laboratories Inc Unit For: 9 July By Investing.com
This article reports on a Form 4 filing for Heart Test Laboratories Inc. on July 9th. It is a brief corporate financial news update from Investing.com. The information provided is minimal and focuses solely on the Form 4 filing date.
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 10 Jul 2026 03:10
- Source
- Investing.com Nigeria
Enterprise value to EBITDA forward of HeartSciences Inc. – NASDAQ:HSCS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 10:35
- Source
- TradingView
Maxim Group Maintains HeartSciences(HSCS.US) With Buy Rating, Maintains Target Price $12
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 01 Jul 2026 07:00
- Source
- Moomoo
HSCS Stock Slides As HeartSciences Wins Key European Patent
HeartSciences Inc. (HSCS) received a new European patent for its ECG-based, machine-learning technology for diastolic heart function, extending its IP protection across 19 countries and bringing its total patents to over 45. Despite this positive news, HSCS stock traded down appr
- Tone
- Negative 41/100
- Event
- Market update
- Published
- 26 Jun 2026 06:41
- Source
- Timothy Sykes
Form 4 Heart Test Laboratories Inc Unit For: 24 June By Investing.com
This article from Investing.com reports on a Form 4 filing for Heart Test Laboratories Inc. related to June 24th. It appears to be a standard financial news brief announcing the filing without providing further details on its content. The article is very brief and acts more as a
- Tone
- Negative 31/100
- Event
- Market update
- Published
- 24 Jun 2026 22:39
- Source
- Investing.com Canada
HeartSciences and Fortitude Announce All-Stock Merger Agreement
HeartSciences and Fortitude Mining Holdings have agreed to an all-stock merger, forming a new Nasdaq-listed company primarily focused on Fortitude's Zcash venture mining platform. Digital Currency Group, Fortitude's current owner, is expected to hold 95% of the combined entity, w
- Tone
- Negative 39/100
- Event
- Deals and strategy
- Published
- 24 Jun 2026 12:09
- Source
- TipRanks
Form 8K Heart Test Laboratories Inc Unit For: 23 June By Investing.com
This article reports on a Form 8K filing by Heart Test Laboratories Inc. related to June 23. It includes a disclaimer about the high risks associated with trading financial instruments and cryptocurrencies, advising investors to be fully informed and seek professional advice.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 22:11
- Source
- Investing.com South Africa
HeartSciences Surges on Planned Merger With Zcash Mining Platform Fortitude | HSCS Stock News
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 07:00
- Source
- Quiver Quantitative
Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Business Wire
Fortitude Mining to merge with HeartSciences in all-stock deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 07:00
- Source
- Investing.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - HeartSciences (NASDAQ:HSCS), Boundless Bio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Benzinga
Fortitude all-stock merger to shift HeartSciences (NASDAQ: HSCS) into Zcash
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 07:00
- Source
- Stock Titan
Zcash miner Fortitude to take over HeartSciences (HSCS) in all-stock deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 Jun 2026 07:00
- Source
- Stock Titan
This Undervalued Medical-Devices Stock Is Poised for a Rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Barron's
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
AI ECG heart test secures patent protection in 19 European countries
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Stock Titan
HSCS - HeartSciences Inc Stock Price and Quote
HeartSciences Inc. (HSCS) specializes in medical technology, using AI-based ECG technology to enhance cardiac screening. The company offers MyoVista, a resting 12-lead ECG that provides diagnostic information for cardiac dysfunction. Recent news includes a business combination wi
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jun 2026 01:09
- Source
- Finviz
UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+
- Tone
- Positive 84/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- eciks.org
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
HeartSciences Stockholders Approve Director Election and Equity Plan
Heart Test Laboratories Inc. (HSCS) held its annual stockholders' meeting where shareholders elected Andrew Simpson as a Class III director and approved an increase in shares under the 2023 Equity Incentive Plan. They also ratified Haskell & White LLP as the independent auditor,
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 May 2026 23:39
- Source
- TipRanks
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- StockStory
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
AI Models Flag HSCS as High-Risk Play Despite Theoretical Upside
AI models, including Perplexity SonarPro and xAI Grok-3, have maintained a cautious, yet slightly less negative, outlook on Heart Test Laboratories (HSCS). They consistently identify HSCS as a high-risk stock due to significant financial strain, cash burn, and weak trading moment
- Tone
- Negative 28/100
- Event
- Balance sheet
- Published
- 05 Apr 2026 13:10
- Source
- TipRanks
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source